Successful exit just 1.5 years after the Company’s founding proves investment rationale Heidelberg, Germany – EMBL Ventures today announced that it has sold its portfolio company Luxendo to Bruker (NASDAQ: BRKR). EMBL Ventures was lead investor with LSP in October 2015 when Luxendo was created as a spin-off by the European Molecular Biology Laboratory (EMBL) […]
Patented SPIM Technology Expands Bruker’s Fluorescence Microscopy Portfolio BILLERICA, Mass. — Bruker today announced that it has acquired Luxendo, a privately held spin-off of the European Molecular Biology Laboratory (EMBL) that develops and manufactures proprietary light-sheet fluorescence microscopy instruments. Luxendo’s proprietary single plane illumination microscopy (SPIM) technique significantly reduces sampling times over conventional laser scanning confocal microscopes, while […]
Avantor to Acquire VWR for $33.25 per Common Share In An All Cash Transaction Valued At $6.4 Billion Avantor’s Acquisition of VWR Will Create a Vertically Integrated, Global Player in Manufacturing and Supply Chain Solutions for the Life Sciences, Advanced Technologies, and Research Industries Combined Company Will Provide Broad Offerings and Compelling Solutions for Customers […]
WALTHAM, Mass.—- PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the company has completed the sale of its Medical Imaging business to Varex Imaging Corporation (Nasdaq: VREX). PerkinElmer announced its intent to sell its Medical Imaging business, a supplier of flat panel X-ray detectors that serve […]
In July 2016, Scientific Laboratory Supplies Ltd (SLS) merged with Dominique Dutscher to create Europe’s largest independent laboratory distributor. Since that time, Dutscher Scientific UK (DSUK) have continued to operate independently in the UK market. With effect from the 1st of May 2017, DSUK will become wholly owned by the SLS Group and their activities […]
Offer price is inadequate Intended takeover of a controlling stake is not in the interest of the company and its shareholders High attendance at the Annual General Meeting is necessary Strategic concept for cooperation has yet to be presented Talks with the Busch family yielded no outcome Pursuant to § 27 of the German Securities […]
Diploma PLC, the international group of businesses supplying specialised technical products and services, is pleased to announce the acquisition of 100% of Abacus ALS Pty Ltd (“Abacus”). Abacus is a long-established supplier of clinical diagnostics instrumentation and consumables to the Pathology and Life Sciences sectors. Abacus has particular strengths in Immunology and Biochemistry testing, supplying […]
Acquisition bolsters Avantor’s portfolio of high-purity cGMP materials and solutions for Biopharma, Research and Electronic Materials customers CENTER VALLEY, PA — Avantor® Performance Materials, LLC, announced today the acquisition of Puritan Products, Inc., a supplier of cGMP buffers and solutions for Biopharma customers, and high-purity chemistries for Research and Electronic Materials customers. Avantor is a global […]
BERWYN, Pa. and MINNEAPOLIS — AMETEK, Inc. (AME) and MOCON, Inc. (MOCO) announced that they have entered into a definitive merger agreement under which AMETEK will acquire all of the outstanding shares of common stock of MOCON at a price of $30 per share in cash, which represents a premium of 39% to MOCON’s closing […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.

